Role of targeted immunotherapy for pancreatic ductal adenocarcinoma (PDAC) treatment: An overview.

Panchal, Kanan; Sahoo, Rakesh Kumar; Gupta, Umesh; Chaurasiya, Akash

Panchal, Kanan; Sahoo, Rakesh Kumar; Gupta, Umesh; Chaurasiya, Akash.

Afiliación

Panchal K; Department of Pharmacy, Birla Institute of Technology and Science, Pilani Hyderabad Campus, Jawahar Nagar, Kapra Mandal, Medchal District, Telangana 500078, India.
Sahoo RK; Department of Pharmacy, School of Chemical Sciences and Pharmacy, Central University of Rajasthan, Bandarsindri, Ajmer, Rajasthan 305817, India.
Gupta U; Department of Pharmacy, School of Chemical Sciences and Pharmacy, Central University of Rajasthan, Bandarsindri, Ajmer, Rajasthan 305817, India.
Chaurasiya A; Department of Pharmacy, Birla Institute of Technology and Science, Pilani Hyderabad Campus, Jawahar Nagar, Kapra Mandal, Medchal District, Telangana 500078, India. Electronic address: dr.akashchaurasiya@gmail.com.

Int Immunopharmacol ; 95: 107508, 2021 Jun.

Article en En | MEDLINE | ID: mdl-33725635

Asunto(s)

Carcinoma Ductal Pancreático/terapia; Inmunoterapia; Neoplasias Pancreáticas/terapia; Animales; Humanos

Palabras clave

Chemotherapy; Immunotherapeutic agents; Immunotherapy; Pancreatic cancer; Pancreatic ductal adenocarcinoma; Targeted immunotherapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático / Inmunoterapia Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Int Immunopharmacol Asunto de la revista: ALERGIA E IMUNOLOGIA / FARMACOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: India

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google